Cargando…

Enhancement of anti-tumour immunity in syngeneic mice after MHC class II gene transfection.

The relationship between tumorigenicity and expression of MHC class II molecules in a class II-negative murine leukaemia cell line (LBC) was studied. Analysis of structural DNA sequences encoding MHC class II proteins was performed by Southern blot with DNA isolated from both the original LB tumour...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mongini, C., Sánchez Lockhart, M., Waldner, C. I., Alvarez, E. M., Gravisaco, M. J., Roig, M. I., Hajos, S. E.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1996
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074574/ https://www.ncbi.nlm.nih.gov/pubmed/8688332

Ejemplares similares

Interleukin 2 exerts autocrine stimulation on murine T-cell leukaemia growth.
por: Waldner, C. I., et al.
Publicado: (1997)

Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours
por: Ong, Chrissie E. B., et al.
Publicado: (2022)

MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
por: Walter, W, et al.
Publicado: (2000)

Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12
por: Barker, S E, et al.
Publicado: (2007)

Tumour-specific antibodies of the IgA class in rats after the implantation of a syngeneic tumour in the gut.
por: Gyure, L. A., et al.
Publicado: (1980)

MHC Class II Presentation in Autoimmunity
por: Ishina, Irina A., et al.
Publicado: (2023)

Structural Properties of MHC Class II Ligands, Implications for the Prediction of MHC Class II Epitopes
por: Jørgensen, Kasper Winther, et al.
Publicado: (2010)

On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases
por: Bernsen, M R, et al.
Publicado: (2003)

Ligation of MHC Class II Induces PKC-Dependent Clathrin-Mediated Endocytosis of MHC Class II
por: Masaki, Kento, et al.
Publicado: (2020)

A transient transfection system for identifying biosynthesized proteins processed and presented to class I MHC restricted T lymphocytes
por: Eisenlohr, Laurence C., et al.
Publicado: (1992)

Superantigen and class II MHC molecules.
por: Kim, J.
Publicado: (1995)

Organizing MHC Class II Presentation
por: Fooksman, David R.
Publicado: (2014)

Expression of MHC class II, interleukin 2 receptor and CD45 antigens on tumour-associated T lymphocytes in colonic carcinoma.
por: Norazmi, M. N., et al.
Publicado: (1989)

Growth of Syngeneic Tumours in Unimmunized Newborn and Adult Hosts
por: Forni, G., et al.
Publicado: (1973)

MHC Class II and Non-MHC Class II Genes Differentially Influence Humoral Immunity to Bacillus anthracis Lethal Factor and Protective Antigen
por: Garman, Lori, et al.
Publicado: (2012)

Discovery of an ancient MHC category with both class I and class II features
por: Okamura, Kazuhiko, et al.
Publicado: (2021)

Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection
Publicado: (1987)

MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis
por: Harrington, Em P, et al.
Publicado: (2023)

Stimulation of syngeneic and allogeneic lymphoid cells by tumour cells in vitro.
por: Potter, M. R., et al.
Publicado: (1975)

MHC Class I Expression by Donor Hematopoietic Stem Cells Is Required to Prevent NK Cell Attack in Allogeneic, but Not Syngeneic Recipient Mice
por: Hirata, Yuichi, et al.
Publicado: (2015)

Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
por: Wieczorek, Marek, et al.
Publicado: (2017)

Transition of tumor-associated macrophages from MHC class II(hi )to MHC class II(low )mediates tumor progression in mice
por: Wang, Benfan, et al.
Publicado: (2011)

PML promotes MHC class II gene expression by stabilizing the class II transactivator
por: Ulbricht, Tobias, et al.
Publicado: (2012)

Model for the Peptide-Free Conformation of Class II MHC Proteins
por: Painter, Corrie A., et al.
Publicado: (2008)

An Oral Salmonella-Based Vaccine Inhibits Liver Metastases by Promoting Tumor-Specific T-Cell-Mediated Immunity in Celiac and Portal Lymph Nodes: A Preclinical Study
por: Vendrell, Alejandrina, et al.
Publicado: (2016)

Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx.
por: Esteban, F., et al.
Publicado: (1990)

MHC Class II Expression in Human Basophils: Induction and Lack of Functional Significance
por: Voskamp, Astrid L., et al.
Publicado: (2013)

Transport of Streptococcus pneumoniae Capsular Polysaccharide in MHC Class II Tubules
por: Stephen, Tom Li, et al.
Publicado: (2007)

An Isotype-specific Activator of Major Histocompatibility Complex (MHC) Class II Genes That Is Independent of Class II Transactivator
por: Douhan, John, et al.
Publicado: (1997)

Effect of solubilized membrane antigens and tumour bearer serum on tumour growth in syngeneic hosts.
por: Forni, G., et al.
Publicado: (1974)

Neoleukin-2 enhances anti-tumour immunity downstream of peptide vaccination targeted by an anti-MHC class II VHH
por: Crowley, Stephanie J., et al.
Publicado: (2020)

Motifs and supermotifs for MHC class II binding peptides
Publicado: (1995)

MHC Class II haplotypes of Colombian Amerindian tribes
por: Yunis, Juan J., et al.
Publicado: (2013)

MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity
por: Tsai, Sue, et al.
Publicado: (2013)

MHC Class II Auto-Antigen Presentation is Unconventional
por: Sadegh-Nasseri, Scheherazade, et al.
Publicado: (2015)

Proteolysis and antigen presentation by MHC class II molecules
por: Bryant, Paula Wolf, et al.
Publicado: (2002)

Hematopoietic Cell Transplantation for MHC Class II Deficiency
por: Lum, Su Han, et al.
Publicado: (2019)

Causal ALS genes impact the MHC class II antigen presentation pathway
por: Chi, Binkai, et al.
Publicado: (2023)

Further Observations on the Effect of C. parvum and Anti-Tumour Globulin on Syngeneically Transplanted Mouse Tumours
por: Woodruff, M. F. A., et al.
Publicado: (1972)

Footprints of antigen processing boost MHC class II natural ligand predictions
por: Barra, Carolina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9m65a1k7p25boie8brb3v018bk